These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3702760)

  • 1. Oestrogens and bone metabolism: a hypothesis.
    Duursma SA; Bijlsma JW; van Paassen HC; Slootweg MC
    Maturitas; 1986 Mar; 8(1):1-6. PubMed ID: 3702760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in serum somatomedin and growth hormone concentrations after 3 weeks oestrogen substitution in post-menopausal women; a pilot study.
    Duursma SA; Bijlsma JW; Van Paassen HC; van Buul-Offers SC; Skottner-Lundin A
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):527-31. PubMed ID: 6540944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone and somatomedin C during post-menopausal replacement therapy with oestrogen alone and in combination with an antioestrogen.
    Fröhlander N; von Schoultz B
    Maturitas; 1988 Mar; 9(4):297-302. PubMed ID: 3380016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ethinyl oestradiol on calcium and bone metabolism in peri- and postmenopausal women.
    Marshall RW; Selby PL; Chilvers DC; Hodgkinson A
    Horm Metab Res; 1984 Feb; 16(2):97-9. PubMed ID: 6706290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
    Riis BJ; Johansen J; Christiansen C
    Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ageing of bone: its relation to osteoporosis and osteoarthrosis in post-menopausal women.
    Dequeker J; Burssens A; Creytens G; Bouillon R
    Front Horm Res; 1975; 3():116-30. PubMed ID: 791695
    [No Abstract]   [Full Text] [Related]  

  • 7. Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and oestrogen replacement.
    Joborn C; Ljunghall S; Larsson K; Lindh E; Naessén T; Wide L; Akerström G; Rastad J
    Clin Endocrinol (Oxf); 1991 May; 34(5):335-9. PubMed ID: 2060142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention and management of post-menopausal osteoporosis.
    Marshall DH; Horsman A; Nordin BE
    Acta Obstet Gynecol Scand Suppl; 1977; 65():49-56. PubMed ID: 269626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of acromegaly with lisuride: differences of effect on growth hormone and somatomedin.
    Marek J; Srámková J; Schüllerová M; Stĕpán J; Schreiberová O
    Endokrinologie; 1981 Dec; 78(2-3):175-85. PubMed ID: 7037372
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of bone loss by hormone replacement therapy is probably not due to stimulation of calcitonin secretion.
    Fletcher CD; Farish E; Leggate J; Hart DM
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):353-6. PubMed ID: 2031433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of somatomedins and growth hormone in relation to bone metabolism in acromegaly and thyroid dysfunction.
    Bijlsma JW; Duursma SA
    Clin Exp Rheumatol; 1986; 4(2):105-10. PubMed ID: 3731567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1,25-dihydroxyvitamin D3 on biochemical indices of bone turnover in postmenopausal women.
    Tjellesen L; Christiansen C; Rødbro P
    Acta Med Scand; 1984; 215(5):411-5. PubMed ID: 6547563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women.
    Kelly JJ; Rajkovic IA; O'Sullivan AJ; Sernia C; Ho KK
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):561-7. PubMed ID: 8252746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone loss during oestriol therapy in postmenopausal women.
    Lindsay R; Hart DM; Maclean A; Garwood J; Clark AC; Kraszewski A
    Maturitas; 1979 Jun; 1(4):279-85. PubMed ID: 399316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone isoenzyme of serum alkaline phosphatase in acromegaly.
    Stĕpán J; Marek J; Havránek T; Dolezal V; Pacovský V
    Clin Chim Acta; 1979 May; 93(3):355-63. PubMed ID: 36248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
    Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis.
    Sugimoto T; Kaji H; Nakaoka D; Yamauchi M; Yano S; Sugishita T; Baylink DJ; Mohan S; Chihara K
    Eur J Endocrinol; 2002 Sep; 147(3):339-48. PubMed ID: 12213671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of bone and soft-tissue operations on serum concentrations of growth hormone, somatomedin C and alkaline phosphatase.
    Casser HR; Zilkens KW; Forst R; Brüggemann A
    Arch Orthop Trauma Surg; 1990; 109(5):272-6. PubMed ID: 2271361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repetitive administration of growth hormone-releasing hormone on growth hormone secretion, insulin-like growth factor I, and bone metabolism in postmenopausal women.
    Franchimont P; Urbain-Choffray D; Lambelin P; Fontaine MA; Frangin G; Reginster JY
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):121-8. PubMed ID: 2911937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.